'On consolidated basis
Quarter ended September 2025 compared with Quarter ended September 2024.
Net sales (including other operating income) of Laurus Labs has increased 35.12% to Rs 1653.47 crore. Operating profit margin has jumped from 14.57% to 24.39%, leading to 126.13% rise in operating profit to Rs 403.26 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 45.16% to 39.87%. Purchase of finished goods cost fell from 2.00% to 1.81%. Employee cost decreased from 13.98% to 12.70%. Other expenses fell from 24.91% to 21.87%.
Other income rose 486.09% to Rs 26.96 crore. PBIDT rose 135.18% to Rs 430.22 crore. Provision for interest fell 23.97% to Rs 40 crore. Loan funds declined from Rs 2,789.03 crore as of 30 September 2024 to Rs 2,211.76 crore as of 30 September 2025. Inventories declined from Rs 2,107.1...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|